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Objectives: Complex aortic aneurysms are being
repaired by endovascular techniques with increasing
frequency. While endovascular aneurysm repair (EVAR) is
generally associated with a reduction in complications com-
pared with open repair, complex EVAR requires the use of
a large-diameter introducer sheath that can occlude arterial
ﬂow to the lower limb. This fact, along with longer procedure
times, suggests that complex EVAR techniques may increase
the risk of lower limb ischemia and reperfusion injury.
Methods: We have adopted the McGill University
sheath-shunt technique (MUSST) whereby an additional
6F or 7F introducer sheath is placed distal to the stent graft
introduction site in antegrade fashion. This sheath is then
connected to the side arm of one of the introducer sheaths
placed in the contralateral limb, allowing continuous perfu-
sion of the limb distal to the stent graft introduction site.
Arterial perfusion distal to the stent graft introduction
site, both before and during shunting, was assessed by
duplex ultrasonography, whereas shunt ﬂow was measured
by transit-time ﬂow measurement.
Results: In our initial experience with seven patients
undergoing complex EVAR, with conﬁrmed occlusion of
the native arterial system by the stent graft introduction
site, occlusion time was 169 6 55 minutes. Use of the
MUSST resulted in pulsatile ﬂow in all cases, with an
average ﬂow of 45 6 10 mL/min. There were no compli-
cations related to the use of this technique.
Conclusions: In patients undergoing complex EVAR
who are at increased risk of lower limb ischemia and
reperfusion injury, the MUSST technique results in
continued perfusion of a limb that would otherwise be
ischemic for a signiﬁcant amount of time. Given the
limited risk of this technique coupled with the potential
beneﬁt, we propose its use in all patients undergoing com-
plex EVAR.
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Management of Thoracic Aortic Endograft Infection
Andrea Kahlberg, Efrem Civilini, Germano Melissano,
Roberto Chiesa. Vascular Surgery, Vita-Salute University,
San Raffaele Scientiﬁc Institute, Milan, ItalyObjectives: Most surveillance after thoracic endovas-
cular aortic repair (TEVAR) concentrates on the technical
aspects of the procedure, including endoleak, device
migration, and endoprosthesis rupture; so far, the knowl-
edge on endoprosthesis infective complications is quite
limited.
Methods: From 1999 to 2013, 478 TEVAR were per-
formed at our institution. In the same period, thoracic
endograft infection (TEI) was identiﬁed in 12 patients
(10 males; mean age, 61.5 years) initially treated for nonin-
fectious disease.
Results: Initial TEVAR was performed at other insti-
tutions in ﬁve patients, and at our institution in seven pa-
tients, for an in-house prevalence of TEI of 1.5%. The
mean time from the index procedure to the diagnosis of
TEI was 14.9 months (range, 1-75 months). Associated
aortoesophageal (AEF) or aortobronchial (ABF) ﬁstula
was found in seven and one patient, respectively. Overall,
three patients died before any surgical treatment could be
performed, eight underwent operations, and one patient
was medically treated. In case of surgical treatment, stent
graft explantation was performed in all cases, with extra-
anatomical revascularization (two cases) or in situ recon-
struction (six cases). Associated tracheal or esophageal
repair was performed in all AEF/ABF cases with different
techniques. In-hospital mortality in the surgical cohort
was 25% (two of eight). Another patient died of sepsis
and bleeding 4 months after the intervention. An AEF or
an ABF was present in 100% of deceased patients. The
other six patients, including the one medically treated,
were alive at a mean follow-up of 43 months (range,
12-108 months).
Conclusions: TEI represents a not negligible late
complication of TEVAR and is associated with an AEF or
ABF in the majority of cases. Surgical treatments include
several technical options, and it is still burdened with
high mortality rates.
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Paraplegia Rates After Branched and Fenestrated
Endograft Repair of Over 1000 Thoracoabdominal
Aneurysms
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Objectives: Open repair has long been considered
the gold standard treatment for thoracoabdominal aortic
aneurysms (TAAAs), with paraplegia rates at centers of
excellence being 3.5 to 7% (observed/expected, 0.11-
0.55). In the last decade, endograft repair (TEVAR)
has largely replaced open repair for thoracic aneurysms.
Although endovascular TAAA repair with branched and
fenestrated endografts (B/FEVAR) is less common
than TEVAR, data on >1000 repairs have been pub-
lished. Our objective was to review the published litera-
ture on B/FEVAR for TAAAs to assess perioperative
and long-term spinal cord ischemia (SCI) and mortality
rates.
